Elicio Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Elicio Therapeutics Operating Expenses Growth & History (ELTX)
Elicio Therapeutics's operating expenses was $37.3M for fiscal 2025.
View full Elicio Therapeutics company overviewElicio Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $37.3M | −$7.7M | −17.09% |
| 2024 | 2024-12-31 | $45.0M | $9.2M | +25.85% |
| 2023 | 2023-12-31 | $35.7M | $9.7M | +37.30% |
| 2022 | 2022-12-31 | $26.0M | −$40.3M | −60.78% |
| 2021 | 2021-12-31 | $66.4M | $12.1M | +22.30% |
| 2020 | 2020-12-31 | $54.3M | — | — |
Elicio Therapeutics quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q3.22
Q1.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $10.4M | $753,000 | +7.78% |
| Q1 2026 | 2026-03-31 | $10.6M | −$134,000 | −1.25% |
| Q4 2025 | 2025-12-31 | $8.8M | — | — |
| Q3 2025 | 2025-09-30 | $8.0M | — | — |
| Q2 2025 | 2025-06-30 | $9.7M | — | — |
| Q1 2025 | 2025-03-31 | $10.7M | — | — |
| Q1 2023 | 2023-03-31 | $7.8M | −$8.3M | −51.62% |
| Q3 2022 | 2022-09-30 | $5.8M | −$11.4M | −66.49% |
| Q1 2022 | 2022-03-31 | $16.1M | −$4.2M | −20.57% |
| Q4 2021 | 2021-12-31 | $10.1M | −$3.8M | −27.66% |
| Q3 2021 | 2021-09-30 | $17.2M | $6.0M | +53.23% |
| Q2 2021 | 2021-06-30 | $18.8M | $1.8M | +10.91% |
| Q1 2021 | 2021-03-31 | $20.3M | $8.1M | +66.67% |
| Q4 2020 | 2020-12-31 | $13.9M | — | — |
| Q3 2020 | 2020-09-30 | $11.2M | — | — |
| Q2 2020 | 2020-06-30 | $16.9M | — | — |
| Q1 2020 | 2020-03-31 | $12.2M | — | — |
Elicio Therapeutics operating expenses trends
Over the last five fiscal years, Elicio Therapeutics's operating expenses decreased from $54.3M to $37.3M, a change of −$17.0M. The latest reported quarter, Q2 2026, shows $10.4M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elicio Therapeutics source filings ↗